7 Biggest Price Target Changes For Tuesday - Amicus Therapeutics (NASDAQ:FOLD), Biomarin Pharmaceutical (NASDAQ:BMRN)

Barclays cut BioMarin Pharmaceutical Inc. BMRN price target from $125 to $105. BioMarin Pharmaceutical shares closed at $88.36 on Monday.
SunTrust Robinson Humphrey lowered the price target on Penntex Midstream Partners LP PTXP from $20 to $18. Penntex Midstream Partners shares closed at $16.69 on Monday.
Imperial Capital lowered the price target for Palo Alto Networks Inc PANW from $190 to $180. Palo Alto Networks shares closed at $136.26 on Monday.
Barclays cut the price target on United Therapeutics Corporation UTHR from $115 to $100. United Therapeutics shares closed at $132.74 on Monday.
Baird cut the price target for Nivalis Therapeutics Inc NVLS from $29 to $3. Nivalis Therapeutics shares closed at $6.25 on Monday.
Leerink Partners lowered the price target for Amicus Therapeutics, Inc. FOLD from $17 to $15. Amicus Therapeutics shares closed at $8.32 on Monday.
Barclays cut the price target for Johnson & Johnson JNJ from $130 to $125. Johnson & Johnson shares closed at $113.13 on Monday.